A malaria vaccine has become the first to provide 100 per cent protection against the disease, confounding critics and surpassing any other experimental malaria vaccine tested, Nature News reports today.
The vaccine, developed and tested in the United States, will now be tested further in clinical trials in Africa, starting at the Ifakara Health Institute in Tanzania. If those are successful, the vaccine may be licensed as early as four years from now.
Image Courtesy of Surachai / FreeDigitalPhotos.net
To read the original article: Early success raises hopes for malaria vaccine
